EPH25 Adverse Drug Events Associated with Immune Checkpoint Inhibitors Atezolizumab, Nivolumab and Pembrolizumab: A Descriptive Retrospective Pharmacoepidemiologic Analysis Using FAERS Database 2014-2021
Abstract
Authors
A. Singh A.L. Hincapie J.J. Guo Y.E. Shin